Use of p16INK4A to achieve reliable, reproducible histological diagnosis in cervical biopsy;Biopsia del cuello uterino ¿es confiable y reproducible el diagnóstico histológico? Utilidad de p16INK4A para lograrlo

Ginecologia y Obstetricia de Mexico

Volumn 75, Issue 10, 2007, Pages 615-620

  Curiel Valdés, José De J ^a,b,c  

^a NOTRE DAME HOSPITAL   (Canada)

^b Academia Nacional de Medicina

^c NONE   (Mexico)

Author keywords

Cervical biopsy; Cervical intraepithelial neoplasia; Diagnostic agreement; P16

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; EOSIN; HEMATOXYLIN; PROTEIN P16; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MEXICO; PATHOLOGIST; STAINING; UTERINE CERVIX CARCINOMA IN SITU; UTERUS BIOPSY; BIOPSY; CHI SQUARE DISTRIBUTION; EVALUATION; HISTOLOGY; PATHOLOGY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX; UTERINE CERVIX TUMOR;

BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CHI-SQUARE DISTRIBUTION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HISTOLOGICAL TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 49449105690     PISSN: 03009041     EISSN: 03009041     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Richart RM. Cervical intraepithelial neoplasia. Pathol Annu 1973;8:301-328.
2. Klaes R, Benner A, Friedrich T, Ridder R, et al. P16INK4A immunohistochemestry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Sug Pathol 2002;26:1389-99.
3. McCluggage WG, Walsh MY, Thornton CM, Hamilton PW, et al. Inter- and intra-observer variation in the histopathological reporting of cervical intraepithelial lesions using a modified bethesda grading system. Br J Obstet Gynaecol 1998;105:206-7.
4. Girardi G, Heras A, Maldonado F, Cordova S, Arias SJ. Immunohistochemestry as diagnostic markers for cervical cancer. Mod Pathol 2003;16:192-6.
5. Yashima K, Ashfaq R, Nowak J, Von-Grueniguen V, et al. Telomerase activity and expression of its RNA component in cervical lesions. Cancer 1998;82:1319-27.
6. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with the p53. Science 1990;248:76-79.
7. Keating JT, Cviko A, Riethdorf S, Riethdorf L, et al. Ki-67, cyclina E, p16INK4A are complimentary surrogate biomarkers for human papillomavirus-related cervical neoplasia. Am J Surg Pathol 2001;25;884-91.
8. Nucci MR, Crum CP. Redefining early cervical neoplasia: recent progress. Adv Anat Pathol 2007;14:1-10.
9. Kong CS, Balzer BL, Troxel ML, Patterson BK, Longacre TA. p16INK4A immunohistochemestry is superior to HPV in situ hibridization for the detection of high-risk HPV in atypical squamous metaplasia. Am J Surg Path 2007;31:33-43.
10. Curiel-Valdés JJ. Trabajo de ingreso a la Academia Mexicana de Cirugía, presentado el 26 de julio 2005 y resumen en Memorias del Congreso EUROGY abril 2006.
11. Kitchener HC, Castle PE, Cox JT. Chapter 7: Achivements and limitations of cervical cytology screening. Vaccine 2006;24(Suppl 3):S63-70.